KURA FY 2013 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$792M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$22,734

Operating Income

-$22,341

Net Income

-$27,315

EPS (Diluted)

$-0.01

Cash Flow

Operating Cash Flow

-$24,418

Free Cash Flow

-$24,418

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$9,068

Total Liabilities

$133,025

Stockholders' Equity

-$123,957

Cash & Equivalents

$6,568

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$22,734	-$22,341	-1.8%
Operating Income	-$22,341	-$23,440	+4.7%
Net Income	-$27,315	-$27,040	-1.0%